The British Horseracing Authority released advice regarding ‘Atrovent’ (ipratropium) on 28th March.
A further note has now been issued (click here) by the BHA reflecting differences in the dose
recommended by Boehringer Ingelheim, scaling from human doses, and reported veterinary field dosages.